Fan GH - Search Results

1

A mixed blessing for liver transplantation patients - Rapamycin.

Fan GH, Zhang CZ, Gao FQ, Wei XY, Ling SB, Wang K, Wang JG, Zheng SS, Nikfarjam M, Xu X. Fan GH, et al. Hepatobiliary Pancreat Dis Int. 2023 Feb;22(1):14-21. doi: 10.1016/j.hbpd.2022.10.004. Epub 2022 Oct 20. Hepatobiliary Pancreat Dis Int. 2023. PMID: 36328894 Review.

2

Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.

Fan GH, Wei RL, Wei XY, Zhang CZ, Qi ZT, Xie HY, Zheng SS, Xu X. Fan GH, et al. Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):433-451. doi: 10.1016/j.hbpd.2021.06.001. Epub 2021 Jun 25. Hepatobiliary Pancreat Dis Int. 2021. PMID: 34233850

3

Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma.

Wei RL, Fan GH, Zhang CZ, Chen KC, Zhang WH, Li CB, Dong SY, Chen JL, Ling SB, Zheng SS, Xu X. Wei RL, et al. Among authors: fan gh. Hepatobiliary Pancreat Dis Int. 2023 Jun;22(3):228-238. doi: 10.1016/j.hbpd.2022.05.005. Epub 2022 May 17. Hepatobiliary Pancreat Dis Int. 2023. PMID: 35613994

4

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis.

Zhang C, Chen K, Wei R, Fan G, Cai X, Xu L, Cen B, Wang J, Xie H, Zheng S, Xu X. Zhang C, et al. Signal Transduct Target Ther. 2020 Mar 27;5(1):23. doi: 10.1038/s41392-020-0105-2. Signal Transduct Target Ther. 2020. PMID: 32296037 Free PMC article.

5

Is the era of sorafenib over? A review of the literature.

Fan G, Wei X, Xu X. Fan G, et al. Ther Adv Med Oncol. 2020 May 26;12:1758835920927602. doi: 10.1177/1758835920927602. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32518599 Free PMC article. Review.

6

NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder.

Fan G, Zhang C, Wei X, Wei R, Qi Z, Chen K, Cai X, Xu L, Tang L, Zhou J, Zhang Z, Lin Z, Xie H, Zheng S, Fan W, Xu X. Fan G, et al. Free Radic Biol Med. 2021 May 1;167:1-11. doi: 10.1016/j.freeradbiomed.2021.02.033. Epub 2021 Mar 8. Free Radic Biol Med. 2021. PMID: 33705959

7

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma.

Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, Wang K, Wei Q, Wei X, Xu X. Tang L, et al. Comput Struct Biotechnol J. 2022 Aug 1;20:4402-4414. doi: 10.1016/j.csbj.2022.07.030. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36051877 Free PMC article.

8

Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.

Wei X, Xie W, Yin W, Yang M, Khan AR, Su R, Shu W, Pan B, Fan G, Wang K, Yang F, Lu D, Li C, Pan L, Cen B, Xie H, Zhuang L, Zheng S, Zeng X, Chen W, Xu X. Wei X, et al. Am J Cancer Res. 2022 Sep 15;12(9):4160-4176. eCollection 2022. Am J Cancer Res. 2022. PMID: 36225628 Free PMC article.

9

SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.

Yuan T, Zhou T, Qian M, Du J, Liu Y, Wang J, Li Y, Fan G, Yan F, Dai X, Li X, Wu Y, Dong X, He Q, Zhu H, Yang B. Yuan T, et al. Hepatology. 2023 Jul 1;78(1):103-119. doi: 10.1002/hep.32621. Epub 2022 Jul 6. Hepatology. 2023. PMID: 35713976

10

Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis.

Zhu H, Wang DD, Yuan T, Yan FJ, Zeng CM, Dai XY, Chen ZB, Chen Y, Zhou T, Fan GH, Ying M, Cao J, Luo P, Liu XJ, Hu Y, Peng Y, He Q, Yang B. Zhu H, et al. Among authors: fan gh. Cancer Res. 2018 Jul 15;78(14):3995-4006. doi: 10.1158/0008-5472.CAN-17-1548. Epub 2018 Apr 18. Cancer Res. 2018. PMID: 29669759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page